Lido Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
9,000
+3,700
+70% +$433K ﹤0.01% 1028
2026
Q1
$638K Sell
5,300
-4,400
-45% -$508K ﹤0.01% 1174
2025
Q4
$1.02M Hold
9,700
﹤0.01% 995
2025
Q3
$814K Buy
9,700
+2,400
+33% +$198K ﹤0.01% 1041
2025
Q2
$578K Buy
7,300
+4,000
+121% +$318K ﹤0.01% 1055
2025
Q1
$296K Hold
3,300
﹤0.01% 1217
2024
Q4
$500K Sell
3,300
-400
-11% -$41.2K ﹤0.01% 1007
2024
Q3
$420K Buy
3,700
+2,100
+131% +$249K ﹤0.01% 1012
2024
Q2
$198K Hold
1,600
﹤0.01% 1289
2024
Q1
$211K Hold
1,600
﹤0.01% 1239
2023
Q4
$174K Buy
1,600
+400
+33% +$41.5K ﹤0.01% 1238
2023
Q3
$124K Hold
1,200
﹤0.01% 1130
2023
Q2
$138K Buy
+1,200
New +$136K ﹤0.01% 1138

Other funds holding MRK

Lido Advisors's MRK Position: Q2 2026 in Review

Lido Advisors increased its Merck (MRK) stake by 15% in Q2 2026, buying an estimated $5.7M and bringing the position to 378,859 shares worth $48.9M. The position accounts for 0.13% of the portfolio, ranked #103.

Lido Advisors first reported a position in MRK in Q2 2016 and has held it in 39 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Lido Advisors held 378,859 shares of Merck worth $48.9M as of Q2 2026.
  • Lido Advisors bought 48,658 Merck shares in Q2 2026, an estimated $5.7M.
  • Merck made up 0.13% of Lido Advisors's portfolio in Q2 2026, its #103 holding.
  • Lido Advisors first reported a position in Merck in Q2 2016 and has held it in 39 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.